These new models are specially trained to recognize when an LLM is potentially going off the rails. If they don’t like how an interaction is going, they have the power to stop it. Of course, every ...
The American Depositary Shares ("ADS") of the United Kingdom-based biotech Compass Pathways plc (CMPS) are soaring today, after management announced its psychedelic drug candidate COMP006 had met the ...
Phase 3 clinical trial data has been a success. COMP360 is the first traditional psychedelic to consistently deliver a highly statistically significant outcome. Results included maintaining a ...
Compass Pathways has reported another phase 3 win for its psilocybin therapy in treatment-resistant depression, sending the British biotech’s share price up 30% and teeing up talks about filing for ...
Compass Pathways (CMPS) added ~20% in the premarket on Tuesday after the U.K.-based biotech announced that its psychedelic therapy COMP360 reached the primary endpoint in a late-stage trial for ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Compass Pathways on ...
Evidence of durability of psilocybin-based COMP360 is a key point for the FDA, according to Compass Pathways Chief Medical Officer Guy Goodwin. By providing 26 weeks’ worth of such data instead of the ...
A psychedelic medicine for hard-to-treat depression could be under approval review before the end of this year, now that its developer has scored positive data from another large clinical trial.
In their closing arguments, attorneys for the two companies addressed claims of collusion, harm to Compass and more. Now a judge will decide what happens next. The preliminary injunction hearing in ...
Compass, the nation’s largest residential real-estate brokerage, has a pitch for home buyers: Sign with us, and you’ll see homes nobody else can. The company maintains a growing inventory of “Private ...
The client, Kyle Blackmon, is a real estate broker with Compass. He was seeking $19.7 million in damages. According to the FINRA arbitration award, Blackmon will receive $5.375 million in compensatory ...
In February 2020, Compass Coffee’s founders put together a presentation for potential investors in their Washington-based company. The deck laid out the owners’ vision: Michael Haft and Harrison ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results